Retinopathy of Prematurity
Ophthalmology·MeSH: Retinopathy of Prematurity
Prevalence
30.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| AKB-10108 | Akebia Therapeutics, Inc. (AKBA) |
Frequently asked questions
How many drugs are in development for Retinopathy of Prematurity?
BioSniper tracks 1 drug in development for Retinopathy of Prematurity across 1 company.
How many clinical trials target Retinopathy of Prematurity?
There are 3 clinical trials targeting Retinopathy of Prematurity tracked by BioSniper.
What is the prevalence of Retinopathy of Prematurity?
The estimated prevalence of Retinopathy of Prematurity is approximately 30.0 per 100,000 population.
Deep-dive into Retinopathy of Prematurity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis